Results 11 to 20 of about 25,803 (305)

Cysteamine Decreases Low‐Density Lipoprotein Oxidation, Causes Regression of Atherosclerosis, and Improves Liver and Muscle Function in Low‐Density Lipoprotein Receptor–Deficient Mice

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2021
Background We have shown previously that low‐density lipoprotein (LDL) can be oxidized in the lysosomes of macrophages, that this oxidation can be inhibited by cysteamine, an antioxidant that accumulates in lysosomes, and that this drug decreases ...
Feroz Ahmad   +8 more
doaj   +2 more sources

Cysteamine exerts in vitro antiviral activity against the SARS-CoV-2 Delta and Omicron variants

open access: yesCell Death Discovery, 2022
The novel SARS-CoV-2 variants of concern (VOC) represent a considerable global alarm because their mutations are known to affect transmissibility and cause immune escape.
Tonino Alonzi   +9 more
doaj   +2 more sources

Effects of Coated Cysteamine on Oxidative Stress and Inflammation in Weaned Pigs

open access: yesAnimals, 2021
This study aimed to explore the effects of dietary coated cysteamine on oxidative stress and inflammation in diquat-induced weaning pigs. Twenty-four pigs were randomly assigned to three dietary groups with eight replicates: the control (fed base diet ...
Shanshan Wang   +8 more
doaj   +2 more sources

Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy

open access: yesCells, 2021
The ongoing pandemic of coronavirus disease-2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), needs better treatment options both at antiviral and anti-inflammatory levels.
Tonino Alonzi   +13 more
doaj   +2 more sources

Challenges for cysteamine stabilization, quantification, and biological effects improvement

open access: yesJournal of Pharmaceutical Analysis, 2020
The aminothiol cysteamine, derived from coenzyme A degradation in mammalian cells, presents several biological applications. However, the bitter taste and sickening odor, chemical instability, hygroscopicity, and poor pharmacokinetic profile of ...
Carla Atallah   +2 more
doaj   +2 more sources

Cysteamine Inhibits Glycine Utilisation and Disrupts Virulence in Pseudomonas aeruginosa

open access: yesFrontiers in Cellular and Infection Microbiology, 2021
Pseudomonas aeruginosa is a major opportunistic human pathogen which employs a myriad of virulence factors. In people with cystic fibrosis (CF) P. aeruginosa frequently colonises the lungs and becomes a chronic infection that evolves to become less ...
Douglas J. Fraser-Pitt   +12 more
doaj   +2 more sources

Spectroscopic Investigation of Cysteamine Dioxygenase

open access: yesBiochemistry, 2020
Thiol dioxygenases are mononuclear non-heme FeII-dependent metalloenzymes that initiate the oxidative catabolism of thiol-containing substrates to their respective sulfinates. Cysteine dioxygenase (CDO), the best characterized mammalian thiol dioxygenase, contains a three-histidine (3-His) coordination environment rather than the 2-His-1-carboxylate ...
Rebeca L. Fernandez   +4 more
openaire   +5 more sources

Influence of supplemented coated-cysteamine on morphology, apoptosis and oxidative stress status of gastrointestinal tract

open access: yesBMC Veterinary Research, 2019
Background Cysteamine was coated to cover its odor and maintain the stability. However, coated cysteamine (CC) has not been clearly evaluated for its effects on the gastrointestinal mucosa status. We hypothesize that the appropriate CC supplementation in
Hongnan Liu   +6 more
doaj   +2 more sources

Is cysteamine use effective in the treatment of melasma? A systematic review and meta‐analysis

open access: yesDermatologic Therapy, 2022
Melasma is a recurrent hypermelanosis disorder characterized by the appearance of brownish and symmetrical spots on the skin. It affects the quality of life and is resistant to available treatment approaches.
Agenor Gomes dos Santos-Neto   +4 more
semanticscholar   +1 more source

Genistein improves renal disease in a mouse model of nephropathic cystinosis: a comparison study with cysteamine

open access: yesHuman Molecular Genetics, 2022
Cysteamine is currently the only therapy for nephropathic cystinosis. It significantly improves life expectancy and delays progression to end-stage kidney disease; however, it cannot prevent it.
Ester De Leo   +14 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy